Daniel Asher has bought stock on 18 days since Jul 2016
10% owner at Ekso Bionics Holdings Inc, and 3 other companies
SEC CIK 0001251859 · Filings on SEC.gov ↗
Daniel Asher's record
3 months after each buy, from the first price a copier could get.
7 buys since 2016 with 3 months of prices.
Companies
Every filing
22 filings since Jul 2016, newest first
Ekso Bionics Holdings, Inc.
10% owner
Ekso Bionics Holdings, Inc.
10% owner
Sequans Communications
10% owner
Sequans Communications
10% owner
Sequans Communications
10% owner
Sequans Communications
10% owner
Sequans Communications
10% owner
Sequans Communications
10% owner
B. Riley Financial, Inc.
10% owner
B. Riley Financial, Inc.
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
National Holdings Corp
10% owner
B. Riley Financial, Inc.
10% owner
B. Riley Financial, Inc.
10% owner
B. Riley Financial, Inc.
10% owner
B. Riley Financial, Inc.
10% owner
B. Riley Financial, Inc.
10% owner
About Daniel Asher
Daniel Asher is a prominent investor and 10% owner of Sequans Communications S.A. (NYSE: SQNS), a fabless semiconductor company specializing in cellular IoT and 5G connectivity solutions.( He holds beneficial ownership of significant stakes through entities he controls, including DBA Trading, LLC (1,853,418 shares) and AFOB FIP MS, LLC (513,443 shares), giving him substantial influence over the company's stock.(
Asher has recently demonstrated strong confidence in Sequans by aggressively increasing his position, purchasing approximately 168,472 shares between January 7 and 16, 2026, for roughly $908,629, at prices ranging from $5.00 to $5.69 per share.( These transactions, including buys of 15,100 shares on Jan. 14 ($5.69), 57,809 on Jan. 13 ($5.51), and others, elevated his total holdings and aligned with insiders owning 9.40% of the company.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.